Viatris (VTRS) is due to report Q2 earnings on August 5, after the closing bell, with analysts projecting a 3% drop in its profits. The company reports revenues under two categories—brands and ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. President Donald Trump has announced plans that would mean all imported ...

New Delhi: After an initial surge, sales of generic versions of the weight-loss drug semaglutide plateaued in June, according to data compiled by sales tracker PharmaTrac. Over the last month the four ...

The Hikma Court correctly held that a generic manufacturer should not be liable for induced patent infringement if it carves patented uses out of its label. FDA can navigate Hikma’s aftermath without ...

Some prestigious brand-name pharmaceutical companies that once looked askance at the high-volume, low-cost business of generic drugs are now becoming major purveyors of generic medicines. Just don't ...

Reliable access to medicines has always mattered, but in today’s healthcare environment it has become a defining issue for pharmacy operations and patient care. Drug shortages, supply disruptions, and ...

“If policymakers genuinely want lower drug prices, the better starting point is stronger (i.e., more certain, reliable and enforceable) patent rights that encourage the development of innovative ...

Rahul Mittal shows how execution infrastructure can improve access, cut delays, and strengthen coordination for generic drug manufacturers in hospitals. The US hospital generics market continues to ...

Eli Lilly's market share in India's weight‑loss drug market fell to 56% in March from 61% in February. Novo Nordisk's market share remained steady at 25%. Indian generic drugmakers have launched 26 ...

A surge in demand since last year for estrogen patches to ease menopause symptoms has strained supplies and led to shortages, sparking a scramble for medicines that industry sources say could last up ...